Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13312-020-1812-z http://scihub22266oqcxt.onion/10.1007/s13312-020-1812-z 32291382!7240229!32291382     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32291382&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Indian+Pediatr 2020 ; 57 (5): 407-410 Nephropedia Template TP {{tp|p=32291382|t=2020. Coronavirus Vaccine: Light at the End of the Tunnel |pdf=|usr=}}{{32291382}} gab.com Text Coronavirus Vaccine: Light at the End of the Tunnel JO: Indian Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=32291382 #FOAvip The world is currently facing an unprecedented global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Predicting the next source of the pandemic can be very challenging. As vaccination is the best way to prevent an infectious disease, the development of an effective vaccine against SARS-CoV-2 can not only reduce the morbidity and mortality associated with it, but can also lessen the economic impact. As the traditional method of vaccine development takes many years for a vaccine to be available to the society, the vaccine development for SARS-CoV-2 should be speeded up using a pandemic approach with fast-track approvals from the regulatory authorities. Various challenges associated with developing a vaccine during the pandemic such as technological hurdles, clinical development pathways, regulatory issues, and support from global funding agencies are expressed here. Twit Text FOAVip Coronavirus Vaccine: Light at the End of the Tunnel ????Indian Pediatr http://www.kidney.de/pget.php?&tw=1&pmid=32291382 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32291382 #FOAvip English Wikipedia <ref>{{Cite pmid|32291382}}</ref> Coronavirus Vaccine: Light at the End of the Tunnel #MMPMID32291382 Ella KM; Mohan VK Indian Pediatr 2020[May]; 57 (5): 407-410 PMID32291382show ga The world is currently facing an unprecedented global pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Predicting the next source of the pandemic can be very challenging. As vaccination is the best way to prevent an infectious disease, the development of an effective vaccine against SARS-CoV-2 can not only reduce the morbidity and mortality associated with it, but can also lessen the economic impact. As the traditional method of vaccine development takes many years for a vaccine to be available to the society, the vaccine development for SARS-CoV-2 should be speeded up using a pandemic approach with fast-track approvals from the regulatory authorities. Various challenges associated with developing a vaccine during the pandemic such as technological hurdles, clinical development pathways, regulatory issues, and support from global funding agencies are expressed here. |*Betacoronavirus[MESH] |*Drug Development[MESH] |*Viral Vaccines[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |Coronavirus Infections/*prevention & control[MESH] |Global Health[MESH] |Humans[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/*prevention & control[MESH] |Research Support as Topic[MESH]Coronavirus Vaccine: Light at the End of the Tunnel (epmc).pdf DeepDyve Pubget Overpricing